The Investment Committee designated by the Romanian Government for the Recovery Equity Fund has approved financing for five new investment funds in Q4 2025, announced the Ministry of Investments and European Projects (MIPE).
Wonderful, the enterprise agent platform builder, announced a $100 million Series A funding round on November 11. The round was led by Index Ventures, with participation from Insight Partners and IVP, alongside existing investors Bessemer and Vine Ventures.
Medicai, a local health-tech startup specializing in cloud-native medical imaging, is expanding its presence in the US market, backed by an investment of approximately €200,000.
GapMinder Fund II announced a €2 million seed investment in Salestools AI, supporting the company's vision to automate and enhance B2B sales processes through autonomous digital agents.
The InvestALIM program, designed to support the development of the food industry, will provide funding for 12 projects with a total investment value of over €300 million.
The BeeFast SaaS platform provides real-time visibility of delivery operations through an intuitive dispatcher tailored to the specific requirements of instant deliveries.
Electrica has completed the Artificial Intelligence for Active Energy Management (AIAE) project, developed in partnership with Romanian startup Renergia and the Technical University of Cluj-Napoca.
Uber Technologies announced new products and features at its annual Go-Get product event, including hotel bookings and travel tools that are planned to roll out globally in the coming months.
Greenvolt Next Romania has signed an agreement with Sam Mills to develop a 2MW photovoltaic project with a 10.03 MWh battery storage system in Satu Mare.
Fitch Ratings has upgraded CEC Bank's Long-Term Issuer Default Rating from BB to BB+ with a Stable Outlook, following the publication of Fitch's updated Bank Rating Criteria on 8 May 2026.
The European Investment Bank (EIB) will advise Antibiotice, Romania's largest pharmaceutical company with majority Romanian capital, on strengthening its corporate governance to support future growth. Under a new advisory services agreement, the EIB will work with Antibiotice to align its risk-management framework and business operations with international best practice in the pharmaceutical sector.